SCPS:OTC-Scopus Biopharma Inc (USD)

COMMON STOCK | Biotechnology |

Last Closing

USD 0.0003

Change

0.00 (0.00)%

Market Cap

USD 0.01M

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-18 )

Largest Industry Peers for Biotechnology

Symbol Name Price(Change) Market Cap
ARGNF argenx SE

N/A

USD 42.38B
UCBJY UCB SA ADR

-2.39 (-2.48%)

USD 37.09B
UCBJF UCB SA

N/A

USD 36.78B
GNMSF Genmab A/S

+1.92 (+0.89%)

USD 12.54B
WXIBF WuXi Biologics

N/A

USD 11.13B
WXXWY WuXi Biologics (Cayman) Inc

+0.05 (+0.83%)

USD 11.13B
IVBIY IVBIY

N/A

USD 7.80B
SBHMY Sino Biopharmaceutical Ltd ADR

N/A

USD 7.33B
ZLDPF Zealand Pharma A/S

N/A

USD 7.23B
AKESF Akeso, Inc.

+0.76 (+9.52%)

USD 7.00B

ETFs Containing SCPS

IEO iShares U.S. Oil & Gas Ex.. 19.39 % 0.42 %

+1.42 (+0%)

USD 0.34B
NRGD 10.00 % 0.00 %

N/A

N/A
NRGU 10.00 % 0.00 %

N/A

N/A
NRGO 10.00 % 0.00 %

N/A

N/A
NRGZ 10.00 % 0.00 %

N/A

N/A
YGRN 10.00 % 0.00 %

N/A

N/A
IS0D:F 9.92 % 0.00 %

N/A

N/A
IS0D:XETRA 9.92 % 0.00 %

N/A

N/A
IOGP:LSE iShares Oil & Gas Explora.. 9.72 % 0.00 %

+0.53 (+0%)

N/A
SPOG:LSE iShares V Public Limited .. 9.72 % 0.00 %

+47.75 (+0%)

N/A
ZPDE:XETRA 8.91 % 0.00 %

N/A

N/A
FRAK 8.73 % 0.54 %

N/A

N/A
SXLE:LSE SPDR S&P U.S. Energy Sele.. 8.69 % 0.00 %

+0.53 (+0%)

N/A
IESU:LSE iShares S&P 500 Energy Se.. 7.85 % 0.00 %

+15.13 (+0%)

N/A
QDVF:F 7.85 % 0.00 %

N/A

N/A
QDVF:XETRA 7.85 % 0.00 %

N/A

N/A
XUEN:XETRA 7.70 % 0.00 %

N/A

N/A
XLE Energy Select Sector SPDR.. 7.69 % 0.13 %

+0.72 (+0%)

USD 32.40B
XSEN:LSE db x-trackers MSCI USA En.. 7.45 % 0.00 %

+27.25 (+0%)

USD 0.07B
XUEN:LSE db x-trackers MSCI USA En.. 7.45 % 0.00 %

+0.04 (+0%)

USD 0.07B
IYE iShares U.S. Energy ETF 7.13 % 0.42 %

+0.36 (+0%)

N/A
FTXN First Trust Nasdaq Oil & .. 7.05 % 0.60 %

+0.29 (+0%)

USD 0.17B
VDE Vanguard Energy Index Fun.. 6.92 % 0.10 %

+0.83 (+0%)

USD 7.69B
JHME 6.90 % 0.48 %

N/A

N/A
NXF-B:CA CI Energy Giants Covered .. 6.76 % 0.00 %

+0.06 (+0%)

CAD 0.02B
DIG ProShares Ultra Oil & Gas 5.99 % 0.95 %

+0.67 (+0%)

N/A
DDG 5.83 % 0.95 %

N/A

N/A
DUG ProShares UltraShort Oil .. 5.83 % 0.95 %

-0.45 (0%)

N/A
ERX Direxion Daily Energy Bul.. 5.71 % 1.08 %

+0.80 (+0%)

N/A
IXC iShares Global Energy ETF 4.98 % 0.46 %

+0.09 (+0%)

N/A
XDW0:XETRA 4.95 % 0.00 %

N/A

N/A
XDW0:LSE db x-trackers MSCI World .. 4.81 % 0.00 %

+0.45 (+0%)

N/A
WNRG:LSE SPDR MSCI World Energy UC.. 4.81 % 0.00 %

+0.49 (+0%)

N/A
ERYY 4.79 % 0.45 %

N/A

N/A
5MVW:XETRA 4.79 % 0.00 %

N/A

N/A
XSD2:LSE db x-trackers ShortDAX x2.. 4.75 % 0.00 %

+1.86 (+0%)

USD 0.11B
DBPD:F 4.75 % 0.00 %

N/A

N/A
HUL-U:CA 4.46 % 0.00 %

N/A

N/A
HUL:CA 4.46 % 2.20 %

N/A

N/A
IGE iShares North American Na.. 4.43 % 0.46 %

+0.02 (+0%)

N/A
GASX 4.29 % 1.01 %

N/A

N/A
FCG First Trust Natural Gas E.. 4.23 % 0.60 %

+0.42 (+0%)

N/A
NANR SPDR S&P® North American.. 3.31 % 0.35 %

-0.09 (0%)

N/A
EQRR ProShares Equities for Ri.. 2.95 % 0.35 %

+0.26 (+0%)

USD 0.01B
HEA-U:CA 2.61 % 0.00 %

N/A

N/A
SPGP Invesco S&P 500 GARP ETF 2.10 % 0.36 %

+0.12 (+0%)

USD 3.79B
GASL 1.45 % 1.19 %

N/A

N/A
TERM 0.88 % 0.64 %

N/A

N/A
JIGB 0.39 % 0.14 %

N/A

N/A
SCHJ Schwab 1-5 Year Corporate.. 0.09 % 0.00 %

+0.03 (+0%)

N/A
OILU MicroSectorsTM Oil & Gas .. 0.00 % 1.22 %

+1.09 (+0%)

USD 0.04B
BWX SPDR® Bloomberg Internat.. 0.00 % 0.50 %

-0.04 (0%)

N/A
EBND SPDR® Bloomberg Emerging.. 0.00 % 0.41 %

-0.04 (0%)

N/A
ILF iShares Latin America 40 .. 0.00 % 0.48 %

-0.28 (0%)

N/A
MTUM iShares MSCI USA Momentum.. 0.00 % 0.15 %

-0.28 (0%)

USD 3.60B
RYE 0.00 % 0.40 %

N/A

N/A
WIP SPDR® FTSE International.. 0.00 % 0.50 %

-0.37 (0%)

N/A
XMEM:LSE Xtrackers MSCI Emerging M.. 0.00 % 0.00 %

-0.50 (0%)

N/A
XMMD:LSE Xtrackers - MSCI Emerging.. 0.00 % 0.00 %

-0.18 (0%)

N/A

Market Performance

  Market Performance vs. Industry/Classification (Biotechnology) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain -92.50% 14% F 5% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -92.50% 14% F 4% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -71.97% 1% F N/A F
Dividend Return -71.97% 1% F N/A F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 38.10% 79% B- 62% D
Risk Adjusted Return -188.92% 1% F N/A F
Market Capitalization 0.01M 10% F 4% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.